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Improved survival of segmental pancreatic homo-
grafts has been obtained in animals using cyclospo-
rine alone for immunosuppression [1,2]. Despite this, 
the results in clinical trials of pancreas transplanta-
tion have remained poor, in part because effective 
ways of draining or eliminating the exocrine drainage 
of the segmental grafts have not been developed [3]. 
Herein we report our experience in dogs with the al-
ternative procedure of total pancreaticoduodenal 
homotransplantation using cyclosporine combined 
with small doses of steroids. 
Material and Methods 
Twenty mongrel dogs of both sexes weighing between 
15 and 25 kg were used as donors or recipients in 10 ex-
periments. The homografts were removed from the donor 
through a midline incision. The transplant specimen was 
prepared, preserving the splenic vessels out to their entry 
into the spleen at the site of splenectomy and retaining the 
hepatic artery throughout its course, including its termi-
nation as the gastroduodenal artery (Figure 1, top). The 
splenic, superior mesenteric, and portal veins were retained 
with the specimen which included both lobes of the pan-
creas as well as the duodenum. The composite organ graft 
was flushed through the celiac axis with chilled, modified 
Collin's solution (TravenoI) and preserved for 2 to 3 
hours. 
The organ complex was revascularized in the left iliac 
fossa with end-to-side anastomoses of the donor celiac axis 
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and portal vein, to the recipient iliac vessels (Figure 1 
above). The proximal duodenum of the graft was closed' 
and the distal end was anastomosed end-to-side to th~ 
proxim~ .recipient jejunum. Either then or a few days later, 
the reCIpIent dog underwent total pancreaticoduodenec-
tomy, Gastrointestinal reconstruction was performed with 
c~lllecystojejunostomy and gastrojejunostomy (Figure 1, 
rIght). 
All d?~s were given intravenous fluids, penicillin, and 
gentamicIn for 5 days postoperatively. The animals were 
allowed to drink water ad libitum after the second post-
ope~ative day and to eat solid food after the fifth postop-
erative day. Immunosuppression consisted of cyclosporine 
at an oral d?se of 17 mg/~g per day beginning on the day 
after operatIon, and predmsone, 0.5 mg/kg per day. Fasting 
glucose concentrations in the venous plasma were mea-
sured daily during the first postoperative week and 3 times 
a week thereafter. Intravenous glucose tolerance tests were 
performed in two dogs who survived more than 60 days. 
The homografts were sampled at the time of sacrifice or at 
autopsy. The formalin-fixed tissues were stained with 
hematoxylin-eosin and examined by light microscopy. 
Results 
The mean survival of the 10 recipients was 50.6 
days. The dogs were normoglycemic for 10 to 210 
days, with a mean of 41.8 days (Table I). The post-
operative blood glucose levels were within normal 
limits during most or all of the postoperative course 
of all 10 dogs. Hyperglycemia developed as a terminal 
event in most of the animals, including three whose 
grafts were rejected. The intravenous glucose toler-
ance test in the two dogs that survived for more than 
60 days showed a rapid recovery from the glucose 
load (Figure 2). 
Graft venous thrombosis, wound dehiscence, and 
acute pancreatitis with intestinal intussusception 
each caused one death. These were considered to be 
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Figure 1. Appearance 01 the homograft (above). Insertion 01 the 
homograft and recipient pancreatlcoduodenectomy with gas-
trointestinal reconstruction (right). 
technical complications. Four dogs died between 16 
and 210 days as the result of marginal ulcer perfo-
ration (two dogs) and hemorrhage (two dogs) at the 
site of the gastrojejunostomy. Three of the 10 deaths 
were attributed to rejection and subsequent diabetes, 
perforation, or both of the grafted duodenum (Table 
I). 
Three of the 10 grafts were necrotic at the time of 
autopsy and were presumed to have been rejected; 
the duodenum had perforated in two of the three. A 
fourth graft was so severely autolyzed from pan-
creatitis that histopathologic analysis of the pancreas 
was not possible (Table II). A fifth graft had a 
thrombosed venous anastomosis with predominant 
TABLE I Dog Survival and Cause of Death 
Normo-
Survival" glycemiat 
Dog (d) (d) Cause of Death 
210 210 Hemorrhage from marginal 
ulcer 
2 23 18 Wound dehiscence; sacri-
ficed 
3 33 26 Hemorrhage from marginal 
ulcer 
4 27 24 Perforated marginal ulcer 
5 13 10 Anastomotic venous throm-
bosis 
6 24 15 Pancreatitis and pseudocyst; 
intussusception 
7 88 63 Rejection; perforation of the 
grafted duodenum 
8 16 16 Perforated marginal ulcer 
9 24 16 Rejection 
10 48 38 Rejection; perforation of the 
grafted duodenum 
• The mean survival was 50.6 days. 
t The mean duration of normoglycemia was 41.8 days. 
678 
histopathologic findings of acute venous congestion. 
The histopathologic findings in the other five grafts 
after 16 to 210 days are summarized in Table II. The 
findings included light to moderate cellular infil-
tration, variable atrophy of the duodenal mucosa, 
and some thickening of the duodenal serosa. The 
exocrine and endocrine pancreatic tissues were sur-
prisingly well preserved. 
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Figure 2. Intravenous glucose lolerance lests In two dogs thaI were 
long-term survivors 01 lolal pancreaticoduodenal homotrans-
plantation. The glucose dose was 0.5 gI kg, and the sample col-
lections were slarted 10 mInutes after complellon of the 5 minute 
InfusIon. 
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Comments 
In the first attempts at whole pancreatic homo-
transplantation in dogs, the pancreas was part of a 
multiple gastrointestinal graft [4]. Five of the un-
treated canine recipients lived for 5.5 to 9 days, and 
during this time the blood sugar levels were nearly 
normal despite the fact that pancreatitis developed 
in four of the five pancreases [4]. Pancreaticoduo-
denal transplantation was first described by De Jode 
and Howard [5], and in 1967 and 1968 Lillehei et al 
[6,7] described a technique of pancreaticoduodenal 
transplantation which differed in only minor details 
from the technique described herein. Under immu-
nosuppression with azathioprine and prednisone, one 
of the pancreaticoduodenal grafts functioned for 
several months [7]. 
The unique value of the composite graft technique 
is that the duodenal component of the organ complex 
can be used to drain the exocrine pancreatic excre-
tions into the recipient gastrointestinal tract without 
jeopardizing the pancreatic duct system [8]. Unfor-
tunately, it has not been possible to exploit this ad-
vantage using conventional immunosuppression with 
azathioprine and prednisone because of the inability 
to consistently control rejection of the duodenum. 
Complications of duodenal rejection have included 
ulceration and perforation and have been so lethal 
that after 1970, Lillehei et al [9] abandoned the 
pancreatic graft in favor of the segmental pancreatic 
transplant [3]. Acceptance of this position has been 
so general that no clinical pancreaticoduodenal 
transplantations have been recorded for anum ber 
of years [3]. 
With the improved immunosuppression that can 
be offered with cyclosporine and steroids, it may be 
appropriate to reassess the pancreaticoduodenal 
procedure. In the present study, the most important 
cause of death was peptic ulceration of the upper 
gastrointestinal tract in the recipient dog, a compli-
cation not of the graft but of the pancreaticoduodenal 
resection used to make the recipient animal diabetic. 
In the four dogs that died from this complication and 
in the dogs that died from dehiscence or graft venous 
throm bosis, the preservation of the grafted duo-
denum was surprisingly good. The duodenal com-
ponent of two necrotic grafts developed perforations, 
but the complications were late and were related to 
necrosis of the entire transplant. In a clinical setting 
there would have been ample time to reoperate and 
remove the graft. 
Summary 
Pancreaticoduodenal transplantation was per-
formed with cyclosporine and steroid immunosup-
pressive therapy in 10 mongrel dogs that had pan-
creaticoduodenectomy. There was an average animal 
survival of 50.6 days and an average duration of 
normoglycemia of 41.8 days. We suggest that pan-
creaticoduodenal transplantation, which was aban-
doned as a clinical procedure 10 years ago, be re-
considered for clinical application. 
References 
1. Dutoit OF. Reece-Smith H. McShane p. Denton T. Morris PJ. 
Prolongation of segmental pancreatic allografts in dogs re-
ceiving cyclosporin A. Transplantation 1982;33:432-7. 
2. McMaster p. Procyskyn A. Caine RY. Valdes R. Rolles K. Smith 
OJ. Prolongation of canine pancreas allograft survival with 
cyclosporin A: preliminary report. Br Med J 1980;280: 
444-5. 
3. Sutherland DER. Report of international human pancreas and 
islet transplantation registry cases through 1981. Diabetes 
1982;31(suppl 4): 112-6. 
4. Starzl TE. Kaupp HA Jr. Brock DR. Butz GW. Linman JW. Ho-
motransplantation of multiple visceral organs. Am J Surg 
1962; 103:219-29. 
5. De Jode LR. Howard JM. Studies in pancreaticoduodenal ho-
motransplantation. Surg Gynecol Obstet 1962; 114:553-8. 
6. Lillehei RC. Idezuki Y. Feemster JA. et al. Transplantation of 
stomach. intestine. and pancreas: experimental and clinical 
observations. Surgery 1967;62:721-41. 
7. Idezuki Y. Feemster JA, Dietzmann RH. Lillehei RC. Experimental 
pancreaticoduodenal preservation and transplantation. Surg 
Gynecol Obste! 1968;126:1002-14. 
8. Orloff MJ. Lee S. Charters AC III. Grambort DE. Storck LG. Knox 
D. Long term studies of pancreas transplantation in experi-
mental diabetes mellitus. Ann Surg 1975;182:198-206. 
9. Lillehei RC. Simmons RL. Najarian JS. Pancreaticoduodenal 
allotransplantation. Experimental and clinical experience. Ann 
Surg 1970;172:405-36. 
Reprinted from the May issue of The American Journal of Surgery. a Yorke Medical Journal. Published by Technical Publishing. 
a Division of Dun-Donnelley Publishing Corporation. a Company of the Dun & Bradstreet Corporation. 875 Third Avenue. New York. N.Y .. 10022. 
Copyright 1984. All rights reserved. Printed in the U.S.A. 
